Related Experiment Video
Updated: May 12, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
PRAMEing a picture of differentiation therapy for AML?
1University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA. redner@pitt.edu
Abstract:
Addition of retinoic acid to chemotherapy improves survival of patients with acute myeloid leukemia. This effect is more pronounced in leukemias that express high levels of PRAME. PRAME is an inhibitor of retinoic acid signaling, which may prove to be an important marker for retinoic acid response.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
11:38A Live-cell Image-Based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation
Published on: October 4, 2024
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Forced Transdifferentiation
Artificial transdifferentiation occurs...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...